Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice

Autor: Brian Fulp, Mary G. Sorci-Thomas, Daniel Kreisel, Alan R. Tall, Melody A. Swartz, Marit Westerterp, Gwendalyn J. Randolph, Shu Hsia Chen, Emmanuel L. Gautier, Catherine Martel, Michael J. Thomas, Andrew M. Platt, Wenjun Li, Robert Bittman
Přispěvatelé: Medical Biochemistry
Rok vydání: 2013
Předmět:
medicine.medical_specialty
Gene Expression
Aorta
Thoracic

Mice
Transgenic

Vascular permeability
030204 cardiovascular system & hematology
Biology
Cholesterol analog
Capillary Permeability
Carcinoma
Lewis Lung

Mice
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
medicine.artery
medicine
Lymphatic vessel
Animals
Macrophage
Skin
Lymphatic Vessels
030304 developmental biology
Mice
Inbred C3H

0303 health sciences
Aorta
Cholesterol
Macrophages
Reverse cholesterol transport
General Medicine
Sinus of Valsalva
Atherosclerosis
Vascular Endothelial Growth Factor Receptor-3
3. Good health
Mice
Inbred C57BL

Kinetics
Endocrinology
medicine.anatomical_structure
Lymphatic system
chemistry
Immunology
Commentary
lipids (amino acids
peptides
and proteins)

Research Article
Zdroj: Journal of clinical investigation, 123(4), 1571-1579. The American Society for Clinical Investigation
ISSN: 0021-9738
Popis: Reverse cholesterol transport (RCT) refers to the mobilization of cholesterol on HDL particles (HDL-C) from extravascular tissues to plasma, ultimately for fecal excretion. Little is known about how HDL-C leaves peripheral tissues to reach plasma. We first used 2 models of disrupted lymphatic drainage from skin - 1 surgical and the other genetic - to quantitatively track RCT following injection of [H-3]-cholesterol-loaded macrophages upstream of blocked or absent lymphatic vessels. Macrophage RCT was markedly impaired in both models, even at sites with a leaky vasculature. Inhibited RCT was downstream of cholesterol efflux from macrophages, since macrophage efflux of a fluorescent cholesterol analog (BODIPY-cholesterol) was not altered by impaired lymphatic drainage. We next addressed whether RCT was mediated by lymphatic vessels from the aortic wall by loading the aortae of donor atherosclerotic Apoe-deficient mice with [H-2](6)-labeled cholesterol and surgically transplanting these aortae into recipient Apoe-deficient mice that were treated with anti-VEGFR3 antibody to block lymphatic regrowth or with control antibody to allow such regrowth. [H-2]-Cholesterol was retained in aortae of anti-VEGFR3-treated mice. Thus, the lymphatic vessel route is critical for RCT from multiple tissues, including the aortic wall. These results suggest that supporting lymphatic transport function may facilitate cholesterol clearance in therapies aimed at reversing atherosclerosis.
Databáze: OpenAIRE